To assess the expression of the STC2 gene across multiple cancer types, we first analyzed STC2 mRNA expression levels in tumor and normal tissues using the TNM platform, which integrates data from Gene Expression Omnibus (GEO), Genotype-Tissue Expression (GTex), The Cancer Genome Atlas (TCGA), and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) databases. Here, STC2 is linked to cancer.